Publikationer

På denne side kan du se publikationer, som Ole har publiceret sammen med andre eller alene.

Hvis du søger noget bestemt, kan du anvende browserens indbyggede søgefunktion ved at trykke på tasterne 'ctrl' og 'b' samtidigt.

De fleste af artiklerne kan rekvireres fra www.pubmed.gov.
 

Artikler

1. Wolthers OD, Stellfeld M. Attendances in a casualty department during a period when direct payment was required for consultations in general practice. J Dan Med Ass 1986; 148: 975-8.

2. Stellfeld M, Wolthers OD, Lildholdt T. Preoperative swabs for the treatment of draining after middle ear surgery. Clin Otolaryngol 1986; 11: 157-9.

3. Wolthers OD, Stellfeld M. Benign mesenchymoma in the trachea in a patient with the nevoid basal cell carcinoma syndrome. J Laryngol Otol 1987; 101: 111-5.

4. Wolthers OD. Paediatric patients in a medical outpatient department. J Dan Med Ass 1987; 149: 2941-4.

5. Wolthers OD, Stellfeld M. A benign mesenchymal tumor of the trachea. J Dan Med Ass 1987; 149: 989-90.

6. Wolthers OD, Aagaard P. Computerized tomography of the liver after percutaneous biopsy. J Dan Med Ass 1988; 150: 1628.

7. Krag-Olsen B, Wolthers OD, Storm K. Mitral incompetence and Marfan´s syndrome in children. J Dan Med Ass 1988; 150: 2825-7.

8. D´Amore F, Wolthers OD. A study of cell-mediated immunity in type 1 diabetes using an antigen presentation assay. Diab Med 1989; 6: 144-8.

9. Wolthers OD. Employment of alternative forms of treatment by patients attending a paediatric outpatient clinic. A questionnaire invesigation. J Dan Med Ass 1989; 151: 87-90.

10.Wolthers OD. Growth problems during childhood. Maanedsskr Prakt Laegeger 1989; 67: 241-8.

11. Storm K, Krag-Olsen B, Wolthers OD. Tuberous sclerosis. J Dan Med Ass 1989; 151: 2962-5.

12. Wolthers OD. Tympanometric screening in children on admission to a paediatric ward. Int J Ped Otorhinolaryngol 1990; 19: 251-7.

13. Wolthers OD. Telephone consultations with the paediatrician-on-call. J Dan Med Ass 1990; 152: 1089-90.

14. Wolthers OD, Skjold E. Secretory otitis media in paediatric patients aged 0-6 years. J Dan Med Ass 1990; 152: 1969-72.

15. Wolthers OD. Do two thirds of sick children have middle ear effusion? Ugeskr Laeger 1990; 152: 2748.

16. Wolthers OD, Pedersen S. Short term linear growth in asthmatic children during treatment with prednisolone. Br Med J 1990; 301: 145-8.

17. Wolthers OD, Pedersen S. Inhaled steroids and growth suppression. Ugeskr Laeger 1990; 152: 2747.

18. Wolthers OD, Pedersen S. Short term linear growth in asthmatic children during treatment with inhaled budesonide: a double blind trial. Br Med J 1991; 303: 163-5.

19. Wolthers OD. Knemometry. Vejlaegen 1991; 8: 10-2.

20. Wolthers OD, Pedersen S. Controlled study of linear growth in asthmatic children during treatment with inhaled glucocorticosteroids. Pediatrics 1992; 89: 839-42.

21. Wolthers OD, Konstantin-Hansen K, Pedersen S, Petersen KE. Knemometry in the assessment of short term linear growth in a population of healthy school children. Horm Res 1992; 37: 156-9.

22. Wolthers OD, Jørgensen BA, Pedersen S. A double-blind, placebo-controlled study of the effect of intranasal budesonide in the treatment of children with seasonal rhinitis. Acta Pædiatr Scand 1992; 81: 902-6.

23. Wolthers OD. Inviolability of the newborn. Ugeskr Laeger 1992; 154: 742-3.

24. Wolthers OD, Pedersen S. Short term growth in children with allergic rhinitis treated with oral antihistamine, depot and intranasal glucocorticosteroids. Acta Pædiatr Scand 1993; 82: 635-40.

25. Wolthers OD, Pedersen S. Short term growth in asthmatic children treated with inhaled fluticasone propionate and beclomethasone dipropionate. Arch Dis Child 1993; 68: 673-6.

26. Agertoft L, Wolthers OD, Fuglsang G, Pedersen S. Nasal powder administration of budesonide for seasonal rhinitis in children and adolescents. Ped All Immunol 1993; 4: 152-6.

27. Wolthers OD, Riis BJ, Pedersen S. Bone turnover in asthmatic children treated with oral prednisolone or inhaled budesonide. Ped Pulm 1993; 16: 341-6.

28. Wolthers OD, Pedersen S. Inhaled budesonide and short term growth. Pediatrics 1993; 91: 517-8.

29. Wolthers OD, Pedersen S. Knemometric assessment of the systemic activity of once daily intranasal dry-powder budesonide in children. Allergy 1994; 49: 96-9.

30. Pedersen S, Wolthers OD. Effects of inhaled glucocorticosteroids on linear growth in children with asthma. Int J Risk Safety Med 1994 (5): 15-30.

31. Wolthers OD, Juul A, Hansen M, Müller J, Pedersen S. The insulin-like growth factor axis and collagen turnover during prednisolone treatment. Arch Dis Child 1994; 71: 409-13.

32. Wolthers OD, Juul A, Hansen M, Müller J, Pedersen S. The insulin-like growth factor axis and collagen turnover in asthmatic children treated with inhaled budesonide. Acta Pædiatr Scand 1995; 84: 393-7.

33. Wolthers OD, Pedersen S. Measures of systemic activity of inhaled glucocorticosteroids in children: a comparison of urine cortisol excretion and knemometry. Respiratory Med 1995; 89: 347-50.

34. Birkebæk NH, Esberg G, Andersen K, Wolthers OD, Hassager C. Bone and collagen turnover during treatment with dry powder budesonide and beclomethasone dipropionate. Arch Dis Child 1995; 73: 524-7.

35. Wolthers OD. Long, intermediate and short term growth studies in asthmatic children treated with inhaled glucocorticosteroids. Eur Respiratory J 1996; 9:821-7.

36. Wolthers OD, Heuck C, Ternowitz T, Heickendorff L, Nielsen HK, Frystyk J. The insulin-like growth factor axis and bone and collagen turnover in children with atopic dermatitis treated with topical glucocorticosteroids. Dermatology 1996; 192: 337-42.

37. Wolthers OD, Hansen M, Juul A, Nielsen HK, Pedersen S. Knemometry, urine cortisol excretion, and measures of the insulin-like growth factor axis and collagen turnover in children treated with inhaled glucocorticosteroids. Pediatric Res 1997; 41 44-50.

38. Wolthers OD. Methodological aspects of short term knemometry in the assessment of exogeneous glucocorticosteroid induced growth effects in children. Ann Hum Biol 1997;24: 539-546.

39. Birkebæk NH, Esberg G, Andersen K, Wolthers OD, Hassager C. Bone turnover in inhaled glucocorticosteroid treated children. J Dan Med Ass 1997; 158: 2559-2562.

40. Heuck C, Wolthers OD. Calculation of knemometric growth rates in group studies of children treated with exogeneous glucocorticosteroids. Ann Hum Biol 1997; 24: 411-418.

41. Wolthers OD, Heuck C, Kollerup G, Hansen M. Serum and urinary markers of type I and III collagen turnover during short term prednisolone treatment in healthy adults. Scand J Clin Lab Invest 1997; 57: 133-140.

42. Heuck C, Wolthers OD, Kollerup G, Hansen M. Short-term growth and collagen turnover in asthmatic adolescents treated with the inhaled glucocorticoid budesonide. Steroids 1997; 62: 659-664.

43. Heuck C, Ternowitz T, Herlin T, Wolthers OD. Short term growth effects of topical glucocorticosteroids in children with atopic dermatitis. Pediatric Derm 1998; 15: 7-11.

44. Wolthers OD, Honour JW. Hypothalamic-pituitary-adrenal function in children with asthma and rhinitis treated with topical glucocorticosteroids. Clin Exper Allergy 1998; 28: 545-550.

45. Wolthers OD, Heuck C. Differential effects of inhaled budesonide on serum osteocalcin in children and adolescents with asthma. Ped All Immunol 1998; 9: 150-155.

46. Heuck C, Wolthers OD, Kollerup G, Hansen M, Teisner B. Adverse effects of inhaled budesonide 800 µg on growth and collagen turnover in asthmatic children: a double blind comparison of once versus twice daily administration. J Pediatrics 1998; 133; 608-612.

47. Heuck C, Skjærbæk C, Wolthers OD. Diurnal rhythm of serum osteocalcin in normal children. Acta Pædiatr Scand 1998; 87: 930-932.

48. Heuck C, Wolthers OD. A placebo-controlled comparison of three osteocalcin assays for assessment of prednisolone induced suppression of bone turnover. J Endocrinol 1998; 159: 127-131.

49 Wolthers OD. Træning i pædiatrisk endokrinologi ved The London Centre of Paediatric Endocrinology and Metabolism. Ugeskr Laeger 1998;

50. Wolthers OD. Knemometry: Administration regimens and topical steroids. Highlights 1998; 6: 1-8.

51. Wolthers OD, Cameron FJ, Scheimberg I, Honour JW, Hindmarsh PC, Savage MO, CGD Brook. Androgen secreting adrenocortical tumours. Arch Dis Child 1999; 80: 46-50.

52. Wolthers OD. Insufflated steroids. Teori og terapi 1999; 2: 18-20.

53. Heuck C, Skjærbæk C, Ørskov H, Wolthers OD. Circadian variation in serum free ultrafiltrable insulin-like growth factor-I in healthy children. Pediatric Res 1999;45: 733-736.

54. Wolthers OD. Nasal steroids. Medicinsk forum 1999; 6: 12-14.

55. Heuck C, Wolthers OD. Serum leptin in children with asthma treated with inhaled budesonide. Respiratory Medicine 1999; 93: 268-271.

56. Wolthers OD. Efficacy and safety of nasal steroids. Pro Medico 1999; 6: 41-43.

57. Wolthers OD, Honour JW. Measures of hypothalamic-pituitary-adrenal function in patients with asthma treated with inhaled glucocorticoids: clinical and research implications. J Asthma 1999; 36: 477-486.

58. Wolthers OD, Heuck C, Skjærbæk C. Diurnal rhythm in serum leptin. J Ped Endocrinol Metab; 1999; 12: 863-866.

59. Wolthers OD. Nasal steroids are effective and safe in allergic rhinitis. Asthma 1999; 4: 5-8.

60. Heuck C, Wolthers OD, Herlin T. Growth suppressive effects of intraarticular glucocorticoids detected by knemometry. Horm Res 2000; 52: 95-96.

61. Wolthers OD, Henriksen JM, Gram S, Skou H. Standarder i behandling af børn med pseudokrup. Rapport til Pædiatrisk specialeråd, Århus Amt og Det nationale indikatorprojekt. Maj 2000.

62. Wolthers OD. Impact of inhaled and intranasal corticosteroids on the growth of children. Biodrugs 2000; 13 (5): 347-357.

63. Wolthers OD. Steroid treatment in children. Maanedsskr Prakt Laeger 2000; 78. 217-227.

64. Wolthers OD, Henriksen J, Gram S, Skou H. Vurdering og behandling af pseudokrup. Medicus Klinisk Info; September 2000: 3-4.

65. Heuck C, Heickendorff L, Wolthers OD. A randomised controlled trial of short term growth and collagen turnover in asthmatics treated with inhaled formoterol and budesonide. Arch Dis Child 2000; 83: 334-339.

66. Wolthers OD. Systemic activity versus systemic adverse effects of nasal glucocorticoids in the treatment of allergic rhinitis. Acta Pædiatrica 2000; 89: 1158-1161.

67. Kjær AK, Gradman C, Heuck C, Wolthers OD. Børns deltagelse i klinisk forskning. Erfaringer fra en undersøgelse af raske børn. Sygeplejersken 2001; 101: 30-35.

68. Wolthers OD. Inhaled corticosteroids and growth. J Pediatr Endocrinol Metab 2001; 14 (6): 1487-1490.

69. Wolthers OD, Schiøler T, Fröhlich A. Akkreditering i sundhedsvæsenet. Intern rapport DSI Institut for sundhedsvæsen, 2001.

70. Wolthers OD, Heuck C, Heickendorff L. Circadian variations in serum and urine markers of type I and type III collagen turnover in children. Clin Chem 2001; 47 (9): 1721-1722.

71. Kjær AK, Gradman C, Heuck C, Wolthers OD. Information til børn i forskningsprojekter. Tandplejeren 2001; 26 (6): 4-9.

72. Wolthers OD, Rumsby G, Techatraisak K, Honour JW, Hindmarsh PC. 17-hydroxylase/17,20-lyase deficiency diagnosed during childhood. Hormone Res 2002; 57: 1333-1336.

73. Herlin T, Birkebæk N, Wolthers OD, Heegaard NHH, Wiik A. Anti-neutrophil cytoplasmic autoantibody (ANCA) profiles in propylthiouracil-induced lupus in monozygotic triplets with hyperthyroidism. Scand J Rheumatol 2002; 31: 46-49.

74. Nickelsen TN, Wolthers OD. Accreditation in Health Services. Focus 2002; 1-23.

75. Wolthers OD, Heuck C. Diurnal leptin rhythms in children treated with prednisolone once daily in the morning or in the evening. J Pediatr Endocrinol Metab 2002; 15: 313-318.

76. Wolthers OD. Growth problems in children with asthma. Hormone Res 2002; 57 (suppl 2): 83-97.

77. Wolthers OD, Heuck C. Short-term treatment with prednisolone has no lasting effect on serum leptin. Scand J Clin Lab Invest 2002; 62: 321-324.

78. Wolthers OD, Allen DB. Inhaled steroids, growth and compliance. N Engl J Med 2002; 347 (15): 1210-1211.

79. Wolthers OD. Flunisolide HFA. Am J Respir Med 2002; 1 (5): 373.

80. Wolthers OD, Heuck C. Circadian variations in serum eosinophil cationic protein (ECP), and serum and urine eosinophil protein X (EPX). Pediatr Allergy Immunol 2003; 14 (2): 130-133.

81. Schou AJ, Heuck C, Wolthers OD. A randomised controlled lower leg growth study of vitamin-D supplementation to healthy children during the Winter season. Ann Hum Biol 2003; 30 (2): 214-219.

82. Wolthers OD. Eosinophil granule proteins in the assessment of airway inflammation in pediatric bronchial asthma. Pediatr Allergy Immunol 2003; 14: 248-254.

83. Schou AJ, Heuck C, Wolthers OD. Vitamin-D supplementation to healthy children does not affect serum osteocalcin or type-I collagen turnover. Acta Paediatr 2003; 92 (7): 797-801.

84. Schou AJ, Heuck C, Wolthers OD. Does vitamin-D administered to children with asthma treated with inhaled glucocorticoids affect short term growth or bone and collagen turnover? Ped Pulm 2003; 36 (5): 399-404.

85. Schou AJ, Heuck C, Wolthers OD. Ultrasound of skin in prednisolone induced short term growth suppression. JPEM 2003; 16 (7): 973-980.

86. Schou AJ, Heuck C, Wolthers OD. Differential effects of short term prednisolone treatment on peripheral and abdominal subcutaneous thickness in Children Assessed by Ultrasound. Steroids 2003; 68 (6): 525-531.

87. Schou AJ, AM Plomgaard, K Thomsen, Wolthers OD. Suppression of lower leg growth in children treated with inhaled glucocorticoids is not accompanied by reduced thickness of cutis or subcutis. Acta Paediatrica 2004;93 (5): 623-627.

88. Schou AJ, AM Plomgaard, K Thomsen, Wolthers OD. High Frequency Ultrasound of Skin in Healthy Children. Skin Res Technol 2004; 10 (3): 200-206.

89. Wolthers OD, Heuck C. Impact of age and administration regimen on the suppressive effect of inhaled glucocorticoids on eosinophil markers in children with asthma. Ped Asthma Allergy Immunol 2004;17(1): 45-52.

90. Wolthers OD, Heuck C. Assessment of the relation between short and intermediate term growth in children with asthma treated with inhaled glucocorticoids. Allergy 2004; 59 (11): 1193-7.

91. Wolthers OD. Sex and gender related differences in children´s evaluation of procedures experienced during participation in clinical research. Eur J Pediatr 2005; 164: 50-51.

92. Schou AJ, Wolthers OD. Short term growth after withdrawal of exogenous glucocorticoids. Hormone Res 2005;64:116-118.

93. Gradman J, Wolthers OD. Longitudinal growth in children with asthma treated with inhaled glucocorticoids. Ugeskr Laeger; 2006; 168: 885-889.

94. Wolthers OD. A questionnaire of factors influencing children´s assent and dissent to non-therapeutic research. J Med Ethics; 2006; 32 (5): 292-297.

95. AM Plomgaard, AJ Schou, OD Wolthers. Short term lower leg growth in asthmatic children treated with inhaled salbutamol. Ann Hum Biol; 2006; 33 (2): 135-144.

96. Gradman J, Wolthers OD. Allergic conjunctivitis in children with asthma, rhinitis and eczema in a secondary outpatient clinic. J Pediatr Allergy Immunol; 2006; Pediatr Allergy Immunol 2006; 17 (7): 524-526.

97. Wolthers OD. Hvilken konsekvens har under- og overbehandling for indsatsen mod astma hos børn? InfoMed 2006; 26: 1-2.

98. Wolthers OD. Systemic activity of inhaled hydroflouroalkane-134a MDI BDP in children with asthma. J Pediatr Astma Allergy Immunol; 2006; 17(8): 613-19.

99. Domene HM, Martinez AS, Frystyk J, Bengola SV, Ropulato MG, Scaglia PA, Chen JW, Heuck C, Wolthers OD, Heinrich JJ, Jasper HG. Normal growth spurt and final height despite low levels of all forms of circulating insulin-like growth factor-I in a patient with acid-labile subunit deficiency. Horm Res 2007; 67 (5): 243-249.

100. Andersen KK, Frystyk J, Wolthers OD, Heuck C, Flyvbjerg A. Gender differences of oligomers and total adiponectin during puberty: a cross sectional study of 859 Danish school children. J Clin Endocrinol Metab 2007; 92(5): 1857-1862.

101. Gradman J, Wolthers OD. Short term growth in children with eczema during treatment with topical mometasone furoate and tacrolimus. Acta Paediatr 2007; 96(8): 1233-1237.

102. Wolthers OD. Systemic activity of inhaled beclomethasone dipropionate hydroflouroalkane-134a in children with asthma. Pediatr Asthma Allergy Immunol 2007; 19(3): 172-179.

103. Pedersen S, Agertoft L, Williams-Herman D, Kuznetsova O, Reiss TF, Knorr B, Dass SB, Wolthers OD. Placebo-controlled study of montelukast and budesonide in short-term growth in prepubertal asthmatic children. Pediatr Pulmonol 2007; 42(9):838-43.

104. Gradman J, Caldwell MF, Wolthers OD. A two-week crossover study to investigate
the effect of fluticasone furoate nasal spray on short-term growth in children with allergic
rhinitis. Clin Ther 2007; 29(8):1738-47.

105. Wolthers OD. Behandling af allergisk rhinitis med nasalsteroid hos børn og unge. BestPractice 2008; 2: 20.

106. Gradman J, Wolthers OD. Suppressive effects of topical mometasone furoate and
tacrolimus on skin prick testing in children. Pediatr Dermatol 2008; 25(2):269-70.

107. Wolthers OD. Hvad betyder guidelines for astmabehandling af born i almen praksis? InfoMed 2008; 19:1-2.

108. Bacharier LB, Boner A, Carlsen KH, Eigenmann PA, Frischer T, Götz M, The European Paediatric Asthma Group. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy 2008;63:5-34.

109. Wolthers OD. Anti-inflammatory treatment of asthma in children: evidence, guidelines and consensus (da). Hospital Healthcare 2008; 12:10-15.

110. Wolthers OD. Tidligere pubertet for astmabørn på steroid? InfoMed 2009; 20: 4.

111. Gradman J, Wolthers OD. A randomised trial of lower leg and height growth in children with asthma treated with inhaled budesonide from a new dry powder inhaler.
J Pediatric Allergy Immunol 2009 Mar 3. [Epub ahead of print]

112. Wolthers OD. Methodology and implications of knemometry in growth assessment of inhaled glucocorticoids. J Pediatric Allergy Immunol 2009 May 2.
[Epub ahead of print]

113. Wolthers OD. Intranasal corticosteroids for treatment of allergic rhinitis (da). Hospital Healthcare 2009; 13: 28-33.

114. Wolthers OD. Anti-inflammatory treatment of asthma: differentiation and trial-and-
error. Acta Paediatr 2009; 98(8): 1237-41.

115. Wolthers OD. Relevance of pharmacokinetics and bioavailability of intranasal corticosteroids in allergic rhinitis. Rec Pat Inflammation Allergy Drug Discov 2010; 482): 118-23.

116. Wolthers OD. Growth suppression caused by corticosteroid eye drops. J Pediatric Endocrinol Metab 2011; 24 (5-6): 393-4.

117. Wolthers OD, Walters EG. Short-term lower leg growth in 5- to 11-year-old asthmatic children using beclomethasone diproponate inhalers with chlorofluorocarbon or hydrofluoroalkane propellants: a 9-week, open-label, randomized, crossover, noninferiority study. Clin Ther 2011; 33(8): 1069-76.

118. Wolthers OD, Sergio F. Systemic activity of inhaled beclomethasone dipropionate: A double blind comparison of volume spacers. Acta Paediatric Scand 2011; jul 25. doi. 10.1111/k- 1651-2227.2011.02430.x. [Epub ahead of print].

119. Schou AJ, Wolthers OD. Serum fructosamine, total cholesterol and high density lipoprotein in children with asthma during glucocorticoid treatment. ISRN Allergy 2011; ID 295124, i:10.5402/2011/295124.

120. Birkebaek N, Frystyk J, Heuck C, Wolthers OD. Growth hormone treatment, final height, insulin like growth factors, ghrelin and adiponectin in four siblings with Seckel syndrome, J Pediatric Endocrinol Metab 2011;24(11-12):995-1000.

121. Wolthers OD. Allergen komponent diagnostik. Laegemagasinet 2012;26:21-27.

122. Wolthers OD. A five-year follow up of human seminal plasma allergy in an 18-year-old woman. CR Medicine 2012; ID 257246: 10.1155/2012/257246.

123. Wolthers OD, Hoest A, Frederiksen B, Halken S. Sublingual immunotherapy in children with allergic rhinitis. Ugesk. Laeger 2012; 174(35):1989-92.

124. Wolthers OD. Resolved component diagnostics in pediatrics. ISRN Pediatrics 2012; epub ID 806920 doi:10.5420/2012/806920.

125. Halken S, Høst A, Videbæk BF, Hansen LG, Wolthers OD. Allergisk rhinokonjunktivitis og børn. Alk Abello 2012:1-7.

126. Wolthers OD, Staberg M. The usefulness of the multiple allergen simultaneous test- chemiluminescent and the phadia immunocap IgE test panel system in children and adolescents. Recent Pat Inflamm Allergy Drug Discov 2013; 7(1):96-99.

127.  Wolthers OD. En ny spiller på holdet: Bilastin, et non-sederende oralt antihistamin. Laegemagasinet 2013;27(1):22-26.

128. Frystyk J, Schou AJ, Heuck C, Vorum H, Lyngholm M, Flyvbjerg A, Wolthers OD. Prednisolone reduces the ability of serum to activate the IGF-I receptor in vitro without affecting circulating total or free IGF-I. Eur J Endocrinol 2013; 168:1-8.

129. Wolthers OD. It is still an open question whether inhaled glucocorticoid-induced  effects may reduce adult height. Evid Based Med 2013; 19:1-2.

130. Dahl R, Wolthers OD, Roenborg S. En ny intranasal behandling af allergisk rhinitis: Kortikosteroidet fluticasone propionate og det non-sederende antihistamin azelastin i samme spray. Laegemagasinet 2013;27(2):20-24.

131. Wolthers OD. Bilastine: a new non-sedating oral H1-antihistamine for treatment of allergic rhinoconjunctivitis and urticaria. Biomed Res Int 2013; 2013:626837. doi: 10.1155/2013/626837. Epub 2013 Jul 14.

132. Wolthers OD. New patents of fixed combinations of nasal antihistamines and corticosteroids in allergic rhinitis. Recent Pat Inflamm Allergy Drug Discov. 2013 Sep;7(3):223-8.

133. Tinggaard J, Aksglæde L, Sørensen K, Mouritsen A, Wohlfahrt-Veje C, Hagen CP, Mieritz MG, Jørgensen N, Wolthers OD, Heuck CW, Petersen JH, Main KM, Juul A. The 2014 Danish references from birth to 20 years for height, weight and body mass index. Acta Paediatr 2013 Oct 15. doi: 10.1111/apa. 12468 (Epub ahead of print).

134. Bidlingmaier M, Friedrich N, Emeny RT, Spranger J, Wolthers OD, Roswall J, Koerner A, Obermayer-Pietsch B, Hübener C, Dahlgren J, Frystyk J, Pfeiffer AF, Doering A, Bielohuby M, Wallaschofski H, Arafat AM. Reference intervals for insulin-like growth-factor-I (IGF-1) from birth to senescence: Results from a multicenter study using a new automates chemiluminescence IGF-1 immunoassay conforming to recent international recommendations. J Clin Immunol Metab 2014; 2014 Feb 27:jc20133059. (Epub ahead of print).

135. Friedrich N, Wolthers OD, Arafat AM, Emeny RT, Spranger J, Roswall J, Kratzsch J, Grabe HJ, Hübener C, Pfeiffer AFH, Doering A, Bielohuby M, Dahlgren J, Wallaschofski H, Bidlingmaier M. Age and sex specific reference intervals across liftespan for insulin-like growth factor binding protein 3 (IGFBP-3) and the IGF-1/IGFBP3 ratio measured by new automated chemiluminescence assays. J Clin Immunol Metab 2014; Jan 31:jc20133060. (Epub ahead of print).

136. Wolthers OD. Ny behandling af allergisk rinitis. Best Practice 2014 (7):34-35.

137. Wolthers OD. Patientvejledning: Revitelle (bilastin) til behandling af høfeber. Et værktøj til, hvordan du bliver klogere på din allergi. Berlin-Chemie Menarini Danmark, marts 2014.

138. Oppenheimer J, Durham S, Nelson H, Wolthers OD. Allergy Diagnostic Testing. WAO, July 2014: http://www.worldallergy.org/professional/allergic_diseases_center/allergy_diagnostic/

139. Wolthers OD. Pharmacokinetics and systemic activity of a new patent of an inhaled corticosteroid/long-acting beta2-agonist combination for use in asthma therapy. Recent Pat Inflamm Allergy Drug Discov 2015; E pub ahead of print. PMID: 26581314.

140. Wolthers OD, Shah T. A comparison of short-term growth during treatment with two dry powder combinations of inhaled corticosteroids and long-acting beta-2 agonists. J Aerosol Med Pulm Drug Deliv. 2015;28(3):182-8.

141. Wolthers OD. Extra-fine inhaled corticosteroids, pharmacokinetics and systemic activity in children with asthma. Pediatr Allergy Immunol. 2015 Sep 11. doi: 10.1111/pai.12491. [Epub ahead of print]. PMID:26360937.

142. Wolthers OD. Fluticasone furoate/vilanterol trifenatate in the treatment of bronchial asthma (Da). Laegemagasinet 2015;29(6):22-27. 

143. Wolthers OD. Budesonide+formoterol fumarate dihydrate for the treatment of asthma. Expert Opin Pharmacol  2016;17(7):1023-30.

144. Wolthers OD. The Sick Songs. Ugeskr Laeger 2016;178(50) (Da). pii: V68935.

145. Wolthers OD. Inhalation therapy of bronchial asthma with a fixed combination of budesonide+formoterol: Evidence still missing (Da). Laegemagasinet 2016; 30(4):34-38.

146. Johansen ML, Hagen CP, Mieritz MG, Wolthers OD, Heuck C, Petersen JH, Juul A. Pubertal progression and reproductive hormones in healthy girls with transient thelarche. J Clin Endocrinol Metab 2017;102(3):1001-1008

147. Wolthers OD, Moore A, Mersmann S, Dissanayake S.Knemometry assessment of short-term lower leg growth in children with asthma treated with fluticasone propionate/formoterol combination therapy. J Aerosol Med Pulm Drug Deliv 2017;30(5):373-380

148. Wolthers OD. Doctors in popular songs: The dark side of the moon? J Br Gen Pract 2017; Jun;67(659):273. doi: 10.3399/bjgp17X691229.

149. Wolthers OD, Stone S, Bareille B, Tomkins S, Khindri S. A randomized, placebo-controlled two-weeks cross-over trial of short-term growth in children with asthma treated with a new inhaled corticosteroid: inhaled fluticasone furoate. Clin Ther 2017;39(6):1191-1199.

150. Wolthers OD. Music is the doctor. Depictions of doctors in popular music (Da). BFL 2017; 208:162-175. 

151. Wolthers OD, Ramshanker N, Heuck C, Frystyk J. The timing of administration of exogenous glucocorticoids affects 24 hour growth hormone secretion in children. J Growth Hormone IGF Res 2017;35:40-44.

152. Wolthers OD, Heuck C. Prednisolone effects on urine-linked N-telopeptides of type I collagen (Ntx) diurnal rhythms in children. Recent Pat Inflamm Allergy Drug Discov 2018;12(2):158-161.

153. Wolthers OD, Mersmann S, Dissanayake S. A pilot study of the normative range of overnight urinary free cortisol corrected for creatinine in children. Clin Drug Invest 2018 Apr;38(4):313-318.

154. Wolthers OD. Non-attendances in a secondary paediatric referral centre. Dan Med J 2018;65(11):A5515:1-3.

155. Wolthers OD. Molecular allergy diagnostics as an adjunct to conventional diagnostics in a secondary paediatric referral centre; Recent Pat Inflamm Allergy Drug Discov 2019 Jun 10. doi: 10.2174/1872213X13666190610143439. [Epub ahead of print] PMID: 31187717. 

156. Wolthers OD. A questionnaire about the risk of growth suppression of inhaled corticosteroids. BrMedJPediatr 2019 Aug 30;3(1):e000533. doi: 10.1136/bmjpo-2019-000533. eCollection 2019.  

157. Wolthers OD. Differential effects of text message reminders on non-attendance and late cancellations in a pediatric outpatient clinic. Dan Med J 2019; 66(11):A5575:1-3.

 

 

 

 

 

 

 

   

 Bøger

1. Wolthers OD. Knemometry in the Assessment of Systemic Activity of Exogeneous Glucocorticosteroids in Children with Asthma and Rhinitis, FadL, Copenhagen, 1996.

2. Wolthers OD. Measurement and Interpretation of Longitudinal Growth (Da). Eli Lilly, Copenhagen, 1996.

3. Wolthers OD, ed. Exogenous Glucocorticoids in Paediatric Asthma. Research Signpost. Kerala, I. 2008.

4. Wolthers OD. Growth Suppression of Inhaled Glucocorticoids in Schoolchildren. In Adverse Effects of Steroids, Inoue I, Watanabe K, eds. Nova Science Publishers, Inc, New York, US, 2009, 135-154.

5.Wolthers OD. DENGANG NU. Bogform, Danmark, 2022.

6. Wolthers OD. FRIT FOR MIT FREMSYN. Digte. Underskoven, Danmark, 2024.
 

Til toppen.